TGTX US,+1

TGTX US,+1

TG Therapeutics in, (TGTX US, +1) – Michael Weiss (CEO, 2011) purchased $350,000 worth of stock on June 26 at $7.04. Weiss is a “Smart Buyer” and has made two timely purchases in TGTX (Sept. 2012 at $2.25 and Dec. 2013 at $3.43) as well as a timely sale in the stock in December 2014 at $16.44. The stock has almost doubled from the beginning of the year but is still below where Weiss sold shares in 2014. After the 50,000 share purchase, Weiss owns 12.8 million shares (14.6% of the company). We are ranking the stock +1.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top